Loading...
Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
BACKGROUND: Tricyclic antidepressants (TCAs) have efficacy in treating irritable bowel syndrome (IBS). Some clinicians use TCAs to treat residual symptoms in inflammatory bowel disease (IBD) patients already on decisive IBD therapy or with quiescent inflammation, although this strategy has not been...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4111227/ https://ncbi.nlm.nih.gov/pubmed/24406434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000000049 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|